PeptideStack
5.2kquestions
20kanswers
220users

Is a 31G needle the right choice for drawing retatrutide at 3.33 mg/mL?

Asked 17 Nov 2025Modified 4 months agoViewed 9.1k times
19

Details up front: a 31G needle · retatrutide · 3.33 mg/mL.

I have used one of these for a while and I am considering switching, which requires a reason.

What I care about is reproducibility, because a result I cannot repeat is not useful to me.

Which axes does this decision turn on?

needle-gauge
needle-gauge

Gauge and length selection, the trade-off between draw time and tissue trauma, coring risk with larger-bore needles, and why a fixed-needle…

91 questions
injection-technique
injection-technique

Technique questions: angle, pinch versus flat, aspiration, injection speed, air bubbles, and the handling steps that determine whether you deliver…

96 questions
dead-space
dead-space

The volume trapped in the syringe hub and needle after the plunger bottoms out. It is small in absolute terms and large as a fraction of a small…

117 questions
retatrutide
retatrutide

An investigational GLP-1, GIP and glucagon receptor tri-agonist, studied in the TRIUMPH programme. Not approved anywhere. Use this tag for…

251 questions
shareeditfollowflag
OS
askedorla_sheridan18k2717 Nov 2025

5 Answers

Accepted answer first, then by votes
43

Accepted answer

At 3.33 mg/mL a 1 mg dose is 0.3 mL — 30 units on a U-100 barrel — and no needle gauge changes that number. Gauge changes three other things: how long the draw takes, how much stays behind in the hub, and how much rubber you core out of the stopper. On the 31G scale a larger number is a finer needle, so a 31G needle is fine enough that a viscous solution draws slowly and a hurried draw pulls bubbles. If you are drawing 30 units at a time, the dead space matters more than the bore: a fixed-needle barrel loses microlitres, a luer hub loses tens of them, and at 3.33 mg/mL each microlitre is 3.33 µg.

For a 4 mm pen-style needle the gauge options are narrow and the choice is nearly made for you.

For injecting, 29G to 31G is the usual range and the difference in perceived discomfort between them is small. Needle length matters more than gauge for comfort at these volumes.

Stated carefully, a 30G or 31G needle through a butyl stopper leaves a track that reseals, which is why fine-gauge repeated entry is tolerable and coarse-gauge repeated entry is not.

Coring risk as a function of needle gauge and insertion technique is documented in pharmacy compounding guidance.

Length affects comfort more than gauge does at these volumes.

shareimprove this answerflag
HL
answered · acceptedharriet_lonsdale35k13811 Feb 2026
Sponsored

Sigma-Aldrich - Certified Reference Materials

Analytical standards and reagents with traceable certificates. Every quantitative result you read inherits the accuracy of the standard behind it.

Shop standards
35

The relevant physics is the fourth-power dependence of flow on radius, which makes small gauge differences enormous in practice.

Very fine needles are more prone to bending and to blocking with any particulate, which is a practical argument for inspecting the solution before drawing.

It helps to be literal here: drawing a viscous or foamy solution through a fine needle takes long enough that people rush the plunger, which causes more foaming. Using a wider drawing needle is the fix.

Needle gauge to outer diameter correspondence is standardised and published; the inverse relationship between gauge number and diameter is the reason for the counter-intuitive labelling.

Flow goes as the fourth power of radius. That is why the difference feels so large.

shareimprove this answerflag
LS
answeredlow_dead_space37k3722 Feb 2026
2Adding a vote because this deserves more of them. – orla_ferriter 12 days ago
add a comment
19

The honest answer is that injection gauge is a comfort decision and drawing gauge is a stopper-coring decision.

Flow through a needle scales with the fourth power of the internal radius under the Hagen–Poiseuille relation. Halving the radius reduces flow sixteen-fold at the same pressure, which is why a 31G needle draws so much more slowly than a 21G.

Stated carefully, fixed-needle insulin syringes are supplied in 29G to 31G and cannot be swapped for drawing, which is the trade-off against their much lower dead space.

The Hagen–Poiseuille relation gives flow proportional to the fourth power of radius, which is the quantitative basis for every gauge recommendation here.

Gauge numbers run backwards. Higher number, thinner needle.

edited 10 Apr 2026 by Dr_Colm_Fitzhenry — added the placebo-arm figures

shareimprove this answerflag
DF
answeredDr_Colm_Fitzhenry69k24716 Mar 2026
16

This is a straightforward answer that people over-complicate because the numbering is counter-intuitive.

Stopper coring — punching a disc of rubber into the solution — is a large-bore phenomenon. An 18G or 21G needle inserted straight and fast is the classic way to do it; inserting at a slight angle with the bevel up reduces the risk.

Butyl rubber closures are specified for resealing after piercing up to a stated gauge, which is the basis for the fine-gauge repeated-entry practice.

The caveat is that no gauge choice makes a non-sterile preparation safe, and research-use compounds are not approved for human use.

Angle the bevel and insert gently to avoid coring the stopper.

edited 11 Mar 2026 by laminar_bench — fixed an arithmetic slip in the third paragraph

shareimprove this answerflag
LB
answeredlaminar_bench69k575 Mar 2026
5Confirming: I did the wrong thing here once and got exactly the predicted result. – Dr_Priya_Raghunathan 7 months ago
6Minor: the filter membrane chemistry matters as much as the pore size for adsorption. – dermot_kiely 9 months ago
add a comment
4

The short version: 21G to 23G to draw, 29G to 31G to inject, and never the same needle for both.

Typical outer diameters: 21G is about 0.82 mm, 23G about 0.64 mm, 25G about 0.51 mm, 29G about 0.34 mm and 31G about 0.26 mm. The gauge number and the diameter move in opposite directions.

Higher gauge is not automatically better; it is thinner, which has costs as well as benefits.

Big to draw, small to inject, never the same one twice.

shareimprove this answerflag
SC
answeredstopper_core28k1279 Dec 2025

Your answer

Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.

Not medical advice. Research-use-only compounds are not approved for human use.